JETi is manufactured by Walk Vascular and sales activity in Germany is supported by Veryan Medical.
For more information about Walk Vascular visit www.jeti.tv
Percutaneous Thrombectomy with the JETi8 Peripheral Thrombectomy System for the Treatment of Deep Vein Thrombosis
Published: January 2020
A retrospective, multi-center, study including 18 consecutive patients evaluating the safety and efficacy of the JETi8 peripheral thrombectomy system in treating acute deep vein thrombosis (DVT). Patients were treated with the JETi8 system to mechanically remove blood clots from the peripheral venous system. The study met the primary endpoint and there were no device related major adverse events.
| Key Results | |
|---|---|
| Mean procedure time | 83 Min |
| Mean thrombus reduction with Jeti alone | 92% |
| Technical success using JETi system alone (no post-op lytic drip required) | 76% |
| Procedural success rate | 100% |
Single-Session Pharmacomechanical Catheter-Directed Thrombolysis Using the JETi Thrombectomy Device for Acute Iliofemoral Deep Vein Thrombosis Refractory to Therapeutic Anticoagulation
Published August 2019
Assessment of the safety and efficacy of the JETi-8 Peripheral Thrombectomy System for the treatment of acute deep vein thrombosis
Presented at: CIRSE 2018